Please log in to view this page
Username
Password
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
